Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -10.64% vs 20.24% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -444.34% vs -1,866.67% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -216.59% vs 29.41% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -2.04% vs -5.77% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Jiangxi Fushine Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -10.64% vs 20.24% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -14.74% vs -30.87% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -444.34% vs -1,866.67% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -36.73% vs -68.80% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -216.59% vs 29.41% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -1,067.92% vs -81.97% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -2.04% vs -5.77% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -3.03% vs -8.33% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






